EMPLOYMENT AGREEMENTEmployment Agreement • October 28th, 2022 • BriaCell Therapeutics Corp. • Pharmaceutical preparations • New York
THIS AGREEMENT is entered into February 14, 2022, and is effective as of February 16, 2022 by and between BriaCell Therapeutics Corp., a Delaware corporation having an address c/o B.Labs, Floor 4, Lab 432, 2929 Arch Street, Philadelphia, PA 19104 (the “Company”), and Giuseppe Del Priore (“Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 28th, 2022 • BriaCell Therapeutics Corp. • Pharmaceutical preparations • Pennsylvania
THIS AGREEMENT is entered into April 16, 2021 and is effective as of May 26, 2021 by and between BriaCell Therapeutics Corp., a Delaware corporation having an address at 820 Heinz Ave., Berkeley, CA 94710 (the “Company”), and Miguel Lopez-Lago, Ph.D. (“Employee”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • October 28th, 2022 • BriaCell Therapeutics Corp. • Pharmaceutical preparations
WHEREAS the Executive is currently a contractor of the Company as its Chief Financial Officer (“CFO”) and has been since February 1, 2016 (the “Hire Date”);
